Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Endometriosis × relugolix × Clear all

Phase

Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3 Pathologic Complete Response 1 Neoplasm, Residual 1 Metastatic Castration-Resistant Prostate Cancer 1 Endometriosis 1 Adenocarcinoma 1

Interventions

vilaprisan 1 relugolix 1 Fluconazole 1 Atorvastatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02093390 2016-06-06

A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjects

Millennium Pharmaceuticals, Inc.

Phase 1 Completed

40 enrolled 23 charts

Endometriosis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡